📈 Markets & Finance
Live
Cathie Wood Is Buying This Up-and-Coming Biotech Stock. Should You Follow Her Lead?
Written by Jeff Siegel for The Motley Fool -> Cathie Wood continues adding shares of Beam Therapeutics. Clinical milestones could transform Beam into a commercial biotech. The stock remains specula
Nasdaq News — 20 July 2026
Text:
7
0
0
Clinical milestones could transform Beam into a commercial biotech. The stock remains speculative, but its upside could be substantial. Cathie Wood
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
YPF executive buys $200,000 in shares at $46.26
📈 Markets & Finance
Indian Shares Open Flat, Tracking Mixed Global Market Cues
📈 Markets & Finance
The World Cup could make 2026 the 'summer of working from home,' says RTO guru Nicholas Bloom
📈 Markets & Finance
REMX hits rare oversold level at 29.98
📈 Markets & Finance
Stock market today: S&P 500, Nasdaq, Dow futures fall as oil surges, Trump declares ceasefire 'over'
📈 Markets & Finance
Weather Channel raises streaming price to $5 a month
